Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tryptophan degradation as a systems phenomenon in inflammation - an analysis across 13 chronic inflammatory diseases.
Harris DMM, Szymczak S, Schuchardt S, Labrenz J, Tran F, Welz L, Graßhoff H, Zirpel H, Sümbül M, Oumari M, Engelbogen N, Junker R, Conrad C, Thaçi D, Frey N, Franke A, Weidinger S, Hoyer B, Rosenstiel P, Waschina S, Schreiber S, Aden K. Harris DMM, et al. Among authors: szymczak s. EBioMedicine. 2024 Apr;102:105056. doi: 10.1016/j.ebiom.2024.105056. Epub 2024 Mar 11. EBioMedicine. 2024. PMID: 38471395 Free PMC article.
Interobserver Reliability of the Nancy Index for Ulcerative Colitis: An Assessment of the Practicability and Ease of Use in a Single-Centre Real-World Setting.
Le HD, Pflaum T, Labrenz J, Sari S, Bretschneider F, Tran F, Lassen A, Nikolaus S, Szymczak S, Kormilez D, Rosenstiel P, Schreiber S, Aden K, Röcken C. Le HD, et al. Among authors: szymczak s. J Crohns Colitis. 2023 Apr 3;17(3):389-395. doi: 10.1093/ecco-jcc/jjac146. J Crohns Colitis. 2023. PMID: 36282973
Blockade of IL-13 signaling improves skin barrier function and biology in patients with moderate to severe atopic dermatitis.
Sander N, Stölzl D, Fonfara M, Hartmann J, Harder I, Suhrkamp I, Jakaša I, van den Bogaard E, van Vlijmen-Willems I, Szymczak S, Rodriguez E, Gerdes S, Weidinger S. Sander N, et al. Among authors: szymczak s. Br J Dermatol. 2024 Mar 26:ljae138. doi: 10.1093/bjd/ljae138. Online ahead of print. Br J Dermatol. 2024. PMID: 38531691
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001.
De Braud F, Deschler-Baier B, Morris JC 3rd, Worden F, Han Y, Kiiskinen U, Jen MH, Barker SS, Szymczak S, Gilligan AM. De Braud F, et al. Among authors: szymczak s. Cancers (Basel). 2023 Dec 27;16(1):140. doi: 10.3390/cancers16010140. Cancers (Basel). 2023. PMID: 38201566 Free PMC article.
96 results